Clinical trial
Colombia Epidemiologic Surveillance Study
NCT00428051 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00428051 |
|---|---|
| Title | Colombia Epidemiologic Surveillance Study |
| Official title | Multinational Latin American Epidemiologic Surveillance For Invasive Pneumococcal Disease |
| Acronym | LEAP II |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Pneumonia, Meningitis, Bacteremia, Sepsis |
| Intervention type | Other |
| Interventions | Surveillance |
| Enrollment | 32,867 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Jan 29, 2007 |
| Last update posted | Oct 27, 2011 |
| Countries | Brazil, Colombia, Costa Rica |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: